ARE THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDELINES THAT PROMULGATE ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER JUSTIFIED BY THE AVAILABLE EVIDENCE?
Roger S. Kirby, John M. FitzpatrickVolume:
102
Year:
2008
Language:
english
Pages:
2
DOI:
10.1111/j.1464-410x.2008.08061.x
File:
PDF, 58 KB
english, 2008